APC
WST icon

Alpine Peaks Capital’s West Pharmaceutical WST Stock Holding History

Alpine Peaks Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.89M Sell
19,191
-10,692
-36% -$3.27M 8.07% 2
2026
Q1 		$7.49M Buy
29,883
+3,400
+13% +$846K 7.55% 2
2025
Q4 		$7.29M Sell
26,483
-350
-1% -$95.7K 6.94% 3
2025
Q3 		$7.04M Buy
26,833
+5,000
+23% +$1.22M 6.11% 4
2025
Q2 		$4.78M Buy
21,833
+600
+3% +$128K 4.21% 13
2025
Q1 		$4.75M Buy
21,233
+1,500
+8% +$413K 4.29% 13
2024
Q4 		$6.46M Sell
19,733
-3,769
-16% -$1.19M 5.31% 9
2024
Q3 		$7.05M Buy
23,502
+2,675
+13% +$819K 4.21% 14
2024
Q2 		$6.86M Hold
20,827
– – 4.21% 13
2024
Q1 		$8.24M Hold
20,827
– – 4.75% 10
2023
Q4 		$7.33M Hold
20,827
– – 4.46% 12
2023
Q3 		$7.81M Sell
20,827
-1,275
-6% -$493K 5.45% 7
2023
Q2 		$8.45M Sell
22,102
-3,425
-13% -$1.22M 5.93% 4
2023
Q1 		$8.84M Sell
25,527
-3,575
-12% -$1.04M 6.68% 2
2022
Q4 		$6.85M Buy
29,102
+2,535
+10% +$601K 5.54% 5
2022
Q3 		$6.54M Buy
26,567
+12,284
+86% +$3.74M 5.87% 2
2022
Q2 		$4.32M Buy
14,283
+1,900
+15% +$618K 5.04% 7
2022
Q1 		$5.09M Buy
12,383
+1,000
+9% +$391K 5.23% 5
2021
Q4 		$5.34M Buy
+11,383
New +$4.9M 5.23% 6

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Alpine Peaks Capital's WST Position: Q2 2026 in Review

Alpine Peaks Capital reduced its West Pharmaceutical (WST) stake by 36% in Q2 2026, selling an estimated $3.27M and leaving 19,191 shares worth $6.89M. The position accounts for 8.07% of the portfolio, ranked #2.

Alpine Peaks Capital first reported a position in WST in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.84M in Q1 2023. 827 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Alpine Peaks Capital held 19,191 shares of West Pharmaceutical worth $6.89M as of Q2 2026.
  • Alpine Peaks Capital sold 10,692 West Pharmaceutical shares in Q2 2026, an estimated $3.27M.
  • West Pharmaceutical made up 8.07% of Alpine Peaks Capital's portfolio in Q2 2026, its #2 holding.
  • Alpine Peaks Capital first reported a position in West Pharmaceutical in Q4 2021 and has held it in 19 quarters since.
  • Alpine Peaks Capital's West Pharmaceutical position peaked at $8.84M in Q1 2023.
  • 827 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Alpine Peaks Capital's 13F filing for Q2 2026, filed 14 Aug 2026.